NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products... Tender

Procurement Summary

Country : USA

Summary : NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)

Deadline : 07 Sep 2020

Other Information

Notice Type : Tender

TOT Ref.No.: 19285628

Document Ref. No. : PAR-18-542

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV

Tender Details

Tender are invited for NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)

CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Sep 07, 2020

Posted Date : Dec 20, 2017

Description: This Funding Opportunity Announcement (FOA) supports the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging therapies) for disorders identified under the NINDS mission. An identified clinical candidate with sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to this CREATE Bio Development Track. Therefore, this FOA supports Investigational New Drug (IND)-enabling studies for a therapeutic candidate and the inclusion of an optional small delayed-onset first in human Phase I clinical trial. At the end of the funding period, a successful project should have at least an IND application submitted to the U.S. Food and Drug Administration (FDA).

Documents

 Tender Notice